Computational Biology Market Report 2026

Computational Biology Market Overview

• Computational Biology market size has reached to $9.47 billion in 2025 • Expected to grow to $27.32 billion in 2030 at a compound annual growth rate (CAGR) of 23.7% • Growth Driver: Rising Demand For Personalized Medicine To Drive Market Growth • Market Trend: Advancements In Mass Spectrometry-Based Proteomics Transforming Computational Biology Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Computational Biology Market?

Computational biology refers to the field of science that teaches students how to use computer science, statistics, and mathematics to solve biological problems. A wide range of biological disciplines, including genomics/genetics, biophysics, cell biology, biochemistry, and evolution, are included in computational biology. The main types of computational biology are in-house and contract. The in-house market consists of sales of computational biological solutions that are performed within a company. The firm uses its own employees and time to perform a business activity, such as financing or brokering. The various tools applied are databases, infrastructure (hardware), and analysis software and services that are used in applications such as cellular and biological simulation, drug discovery and disease modelling, and clinical trials. The industries that have adopted computational biology are research, the pharmaceutical industry, and commercial applications.

What Is The Computational Biology Market Growth Forecast?

The computational biology market size is expected to see exponential growth in the next few years. It will grow to $27.32 billion in 2030 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to increasing demand for precision medicine solutions, rising investments in drug discovery analytics, expansion of cloud-based bioinformatics platforms, growing use of ai-driven biological insights, increasing reliance on data-driven clinical research. Major trends in the forecast period include increasing use of algorithm-driven biological modelling, rising adoption of in-silico drug discovery tools, growing integration of multi-omics data analysis, expansion of high-performance computing in biology, enhanced focus on predictive biological simulations.

What Is The Driver Of The Computational Biology Market?

The increasing demand for personalized medicine is expected to propel the growth of computational biology going forward. Personalized medicine, also known as precision medicine, is an approach to medical treatment and healthcare that takes into account individual variability in genes, environment, and lifestyle when developing treatment plans for patients. Personalized medicine relies on analyzing an individual's genetic data to tailor medical treatments. Computational biology plays a vital role in interpreting this genetic information, enabling the development of targeted therapies, optimizing treatment regimens, and predicting treatment outcomes. It helps stratify patients into specific subgroups, reduces healthcare costs, and aligns with regulatory and clinical guidelines. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, said the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the computational biology industry.

Key Players In The Global Computational Biology Market

Major companies operating in the computational biology market are Certara L.P.; Chemical Computing Group Inc.; Compugen Ltd.; Genedata AG; Dassault Systèmes SE; Rosa & Co. LLC; Simulation Plus Inc.; Nimbus Discovery LLC; Rhenovia Pharma SAS; DNAnexus; Genialis Inc.; BC Platforms; Schrodinger Inc.; Strand Life Sciences; Numerate Inc.; Insitro; Recursion Pharmaceuticals; Atomwise; Relay Therapeutics; Exscientia

Global Computational Biology Market Trends and Insights

Major companies operating in the computational biology market are developing new solutions for proteomics research to gain a competitive edge in the market. Proteomics research is a field of scientific study focused on the comprehensive analysis of proteins in a biological system. For instance, in May 2023, Biognosys AG, a Switzerland-based biotechnology company, launched Spectronaut 18 and unveiled significant scientific and technological enhancements for its exclusive proteomics research software and offerings. Spectronaut 18 offers high throughput and efficiency in data-independent acquisition (DIA) proteomics analysis. The company's TrueDiscovery platform accelerates biomarker discovery in fields like oncology and neuroscience by providing unparalleled depth and sensitivity in proteomics. TrueTarget enables high-resolution drug target identification and deconvolution, and Biognosys' iRT Kit, recommended for real-time system suitability monitoring, is now supported in combination with Bruker ProteoScape software.

What Are Latest Mergers And Acquisitions In The Computational Biology Market?

In August 2023, Optibrium Ltd., a UK-based provider of software and AI solutions for drug discovery, acquired BioPharmics LLC for an undisclosed amount. Through this acquisition, Optibrium aims to strengthen its 3D ligand- and structure-based computational drug design capabilities by integrating BioPharmics’ specialized algorithms and software tools. BioPharmics LLC is a US-based company that provides algorithms and software for 3D ligand- and structure-based computational drug design, including molecular docking, 2D-to-3D ligand conversion, conformer generation, molecular similarity, and binding affinity prediction.

What Defines the Computational Biology Market?

The computational biology market includes revenues earned by entities by providing biological notions rigor and verifiability, as well as by offering a framework that connects diverse insights. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Computational Biology Market Report 2026?

The computational biology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the computational biology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.